Literature DB >> 7668032

Influenza vaccination in 18 developed countries, 1980-1992.

D S Fedson1, C Hannoun, J Leese, M J Sprenger, A W Hampson, K Bro-Jørgensen, A M Ahlbom, H Nøkelby, M Valle, O Olafsson.   

Abstract

Influenza continues to be an important cause of preventable morbidity and mortality. Although influenza vaccine is widely recommended for older high-risk individuals, no studies have compared its use in different countries. We gathered information on influenza vaccine distribution in 18 developed countries for the period 1980-1992. During the 1980s there was a > or = 10-fold difference in annual per capita vaccine distribution among these countries, and in 1992 the difference was still more than 7-fold. Several countries demonstrated large increases in vaccine use over the study period, some showing substantial increases in specific years. Thirteen of the 18 countries recommend influenza vaccination for all elderly persons and 11 countries provide reimbursement for vaccination through national or social health insurance. These countries tend to have higher levels of vaccine use. Historical, economic and political factors also affect vaccination practices and policies, but their relationships to differences in vaccine use between countries are not known. A better understanding of why the use of influenza vaccine varies among countries will be important if its protective benefits are to be fully realized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668032     DOI: 10.1016/0264-410x(94)00041-k

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Influenza vaccination in 29 countries. An update to 1997.

Authors:  F Ambrosch; D S Fedson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  Evaluating the impact of influenza vaccination. A North American perspective.

Authors:  D S Fedson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

3.  New and not so new vaccines.

Authors:  T Jefferson
Journal:  BMJ       Date:  1996-09-28

Review 4.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

5.  Socioeconomics of influenza and influenza vaccination in Europe.

Authors:  K G Nicholson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

6.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands.

Authors:  E Hak; G A van Essen; E Buskens; W Stalman; R A de Melker
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

7.  Influenza vaccination in Austria, 1982-2003.

Authors:  Ursula Kunze; Ernest Groman; Gabriela Böhm; Michael Kunze
Journal:  Wien Med Wochenschr       Date:  2007

Review 8.  Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data.

Authors:  Jason M Nagata; Isabel Hernández-Ramos; Anand Sivasankara Kurup; Daniel Albrecht; Claudia Vivas-Torrealba; Carlos Franco-Paredes
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

9.  Coverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation.

Authors:  Maria Ganczak; Karolina Gil; Marcin Korzeń; Marta Bażydło
Journal:  Int J Environ Res Public Health       Date:  2017-06-20       Impact factor: 3.390

10.  Beliefs and attitudes towards the influenza vaccine in high-risk individuals.

Authors:  A J Santos; I Kislaya; A Machado; B Nunes
Journal:  Epidemiol Infect       Date:  2017-04-24       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.